These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 23076845

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome.
    Menke LA, Sas TC, de Muinck Keizer-Schrama SM, Zandwijken GR, de Ridder MA, Odink RJ, Jansen M, Delemarre-van de Waal HA, Stokvis-Brantsma WH, Waelkens JJ, Westerlaken C, Reeser HM, van Trotsenburg AS, Gevers EF, van Buuren S, Dejonckere PH, Hokken-Koelega AC, Otten BJ, Wit JM.
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1151-60. PubMed ID: 20061421
    [Abstract] [Full Text] [Related]

  • 3. The effect of oxandrolone on voice frequency in growth hormone-treated girls with Turner syndrome.
    Menke LA, Sas TC, van Koningsbrugge SH, de Ridder MA, Zandwijken GR, Boersma B, Dejonckere PH, de Muinck Keizer-Schrama SM, Otten BJ, Wit JM.
    J Voice; 2011 Sep; 25(5):602-10. PubMed ID: 20971614
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effect of the weak androgen oxandrolone on psychological and behavioral characteristics in growth hormone-treated girls with Turner syndrome.
    Menke LA, Sas TC, Visser M, Kreukels BP, Stijnen T, Zandwijken GR, de Muinck Keizer-Schrama SM, Otten BJ, Wit JM, Cohen-Kettenis PT.
    Horm Behav; 2010 Mar; 57(3):297-305. PubMed ID: 20053349
    [Abstract] [Full Text] [Related]

  • 6. Safety and efficacy of oxandrolone in growth hormone-treated girls with Turner syndrome: evidence from recent studies and recommendations for use.
    Sas TC, Gault EJ, Bardsley MZ, Menke LA, Freriks K, Perry RJ, Otten BJ, de Muinck Keizer-Schrama SM, Timmers H, Wit JM, Ross JL, Donaldson MD.
    Horm Res Paediatr; 2014 Mar; 81(5):289-97. PubMed ID: 24776783
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Oxandrolone for growth hormone-treated girls aged up to 18 years with Turner syndrome.
    Mohamed S, Alkofide H, Adi YA, Amer YS, AlFaleh K.
    Cochrane Database Syst Rev; 2019 Oct 30; 2019(10):. PubMed ID: 31684688
    [Abstract] [Full Text] [Related]

  • 10. The effect of oxandrolone on body proportions and body composition in growth hormone-treated girls with Turner syndrome.
    Menke LA, Sas TC, Zandwijken GR, de Ridder MA, Stijnen T, de Muinck Keizer-Schrama SM, Otten BJ, Wit JM.
    Clin Endocrinol (Oxf); 2010 Aug 30; 73(2):212-9. PubMed ID: 20105186
    [Abstract] [Full Text] [Related]

  • 11. Influence of hormonal therapy on growth rate and bone age progression in patients with Turner syndrome.
    Gawlik A, Gawlik T, Koehler B, Malecka-Tendera E, Augustyn M, Woska W.
    Endokrynol Pol; 2005 Aug 30; 56(2):136-44. PubMed ID: 16335681
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of oxandrolone and timing of oral ethinylestradiol initiation on pubertal progression, height velocity and bone maturation in the UK Turner study.
    Perry RJ, Gault EJ, Paterson WF, Dunger DB, Donaldson MD.
    Horm Res Paediatr; 2014 Aug 30; 81(5):298-308. PubMed ID: 24751470
    [Abstract] [Full Text] [Related]

  • 15. Long-term results of growth hormone therapy in Turner syndrome.
    Bramswig JH.
    Endocrine; 2001 Jun 30; 15(1):5-13. PubMed ID: 11572325
    [Abstract] [Full Text] [Related]

  • 16. Karyotype-specific ear and hearing problems in young adults with Turner syndrome and the effect of oxandrolone treatment.
    Verver EJ, Freriks K, Sas TC, Huygen PL, Pennings RJ, Smeets DF, Hermus AR, Menke LA, Wit JM, Otten BJ, van Alfen-van der Velden JA, de Muinck Keizer-Schrama SM, Topsakal V, Admiraal RJ, Timmers HJ, Kunst HP.
    Otol Neurotol; 2014 Oct 30; 35(9):1577-84. PubMed ID: 25133471
    [Abstract] [Full Text] [Related]

  • 17. Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height.
    Quigley CA, Crowe BJ, Anglin DG, Chipman JJ.
    J Clin Endocrinol Metab; 2002 May 30; 87(5):2033-41. PubMed ID: 11994337
    [Abstract] [Full Text] [Related]

  • 18. Effect of oxandrolone on glucose metabolism in growth hormone-treated girls with Turner syndrome.
    Menke LA, Sas TC, Stijnen T, Zandwijken GR, de Muinck Keizer-Schrama SM, Otten BJ, Wit JM.
    Horm Res Paediatr; 2011 Feb 30; 75(2):115-22. PubMed ID: 20814189
    [Abstract] [Full Text] [Related]

  • 19. Normalization of height in girls with Turner syndrome after long-term growth hormone treatment: results of a randomized dose-response trial.
    Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, Jansen M, Otten BJ, Hoorweg-Nijman JJ, Vulsma T, Massa GG, Rouwe CW, Reeser HM, Gerver WJ, Gosen JJ, Rongen-Westerlaken C, Drop SL.
    J Clin Endocrinol Metab; 1999 Dec 30; 84(12):4607-12. PubMed ID: 10599727
    [Abstract] [Full Text] [Related]

  • 20. Final height outcome in girls with Turner syndrome treated with a combination of low dose oestrogen and oxandrolone.
    Bareille P, Massarano AA, Stanhope R.
    Eur J Pediatr; 1997 May 30; 156(5):358-62. PubMed ID: 9177976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.